A nurse is assessing a client who has received oxycodone. The nurse notes that the client's respiratory rate is 8/min. The nurse should identify that which of the following is the pathophysiology for the client's respiratory rate?
Oxycodone blocks the sodium channel suspending nerve conduction.
Oxycodone inhibits prostaglandin synthesis.
Oxycodone promotes vasodilation of cranial arteries.
Oxycodone uses central nervous system depression.
The Correct Answer is D
A. Oxycodone primarily exerts its analgesic effects through binding to opioid receptors and modulating neurotransmitter release, rather than blocking sodium channels.
B. Oxycodone does not directly inhibit prostaglandin synthesis; this mechanism is associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
C. Oxycodone does not promote vasodilation of cranial arteries. This mechanism is more commonly associated with medications used to treat migraines, such as triptans.
D. Oxycodone is an opioid analgesic that acts centrally on the nervous system to depress respiratory drive, leading to respiratory depression, especially at higher doses.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. The client has a history of anaphylaxis following a bee sting: This finding is not directly related to the safety of taking alendronate for osteoporosis.
B. The client has a first-degree relative who has Paget's disease: While family history is
important in assessing the risk of osteoporosis, it is not a direct safety risk for taking alendronate.
C. The client is postmenopausal: Postmenopausal status is a common indication for the use of alendronate to prevent or treat osteoporosis. It is not a safety risk.
D. The client has immobility that restricts her to a supine position: Immobility, especially in a supine position, can increase the risk of esophageal irritation and reflux when taking alendronate. Therefore, this finding poses a safety risk for the client when taking this medication.
Correct Answer is D
Explanation
A. Verapamil: Verapamil is a calcium channel blocker primarily used to treat supraventricular
tachycardias, not ventricular dysrhythmias. It is not typically used for life-threatening ventricular dysrhythmias.
B. Digoxin: Digoxin is a cardiac glycoside used primarily for atrial fibrillation and heart failure, not ventricular dysrhythmias. It is not typically used for life-threatening ventricular
dysrhythmias.
C. Dopamine: Dopamine is a sympathomimetic medication used for hemodynamic support in hypotension and shock. While it may be used in some cases of unstable bradycardia, it is not the first-line medication for life-threatening ventricular dysrhythmias.
D. Amiodarone: Amiodarone is an antiarrhythmic medication used for the treatment of various ventricular and supraventricular dysrhythmias, including life-threatening ventricular
dysrhythmias such as ventricular tachycardia and ventricular fibrillation. It is often used as a first-line medication for these conditions due to its efficacy and safety profile. Therefore, the nurse should anticipate administering amiodarone for the client's life-threatening ventricular dysrhythmia.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.